Typicality: | 0.349 |
Saliency: | 0.233 |
in the u.s. | 7 | location |
for new formulations of kl4 surfactant | 3 | transitive-object |
patent → provide → exclusivity | 6 |
patent → provide → market exclusivity | 5 |
patent → give → exclusivity | 4 |
negative | neutral | positive |
0.115 | 0.592 | 0.293 |
Raw frequency | 15 |
Normalized frequency | 0.233 |
Modifier score | 0.500 |
Perplexity | 154.144 |